New pain combo eases liver cancer procedure recovery
NCT ID NCT07315022
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a combination of two pain medicines (hydromorphone and flurbiprofen) could help control pain during and after a liver cancer treatment called TACE. 129 adults with intermediate-to-advanced liver cancer took part. The goal was to see if this approach could reduce pain and side effects, helping patients recover faster.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENHANCED RECOVERY AFTER SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could talking directly to teens before surgery ease their pain?
- Could a Two-Level nerve block better tame breast surgery pain?
- Single incision vs. multiple: which hysterectomy technique gets you home faster?
- Can a structured recovery plan speed healing after emergency gallbladder surgery?
- 45,000 hip and knee replacements analyzed to improve day-surgery success
- Catheter timing could cut infections and speed recovery after colorectal surgery